Inhaled IL-4 halts neuron destruction in MS models

An US-German team has found a way to halt the inflammatory brain cell destruction in mice with multiple sclerosis (MS) without suppression of the human immune system.

ADVERTISEMENT

The researchers headed by Frauke Zipp from University Hospital Mainz, Germany, say their findings could pave the way toward unconventional and much-needed treatment strategies to alleviate neuron injuries that stem from brain inflammation (Science Transl. Medicine: doi: 10.1126/scitranslmed.aao2304)

Most approaches for treating multiple sclerosis aim to reduce the numbers of inflammatory activated T lymphocytes that destroy the myelin insulatiuon around neurons that accelerate transmission of signal transmission. The researchers leveraged the fact that although T cells can contribute to the progression of autoimmune diseases like multiple sclerosis, they also help maintain normal tissue function in healthy people. Searching for a signal from T cells that might be beneficial for healing nerve damage, the researchers narrowed in on a cytokine named IL-4.

In mice with a disease that mimics several aspects of multiple sclerosis, IL-4 injections alleviated neuron damage and caused marked improvements in the treated animals’ walking abilities. Importantly, similar benefits occurred when IL-4 was administered through nasal inhalation. What’s more, IL-4 treatment didn’t alter immune activity in the mice, instead the signaling molecule prevented break down of the long, thread-like projections called axons that allow nerve cells to transmit signals. The researchers showed that the receptor for IL-4 was present on axons in samples from human patients with multiple sclerosis. According to the authors, further studies should investigate optimum IL-4 dosing in animal models and potential side effects before proceeding to clinical trials.

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!